サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1434577

3D細胞培養市場：製品、用途、エンドユーザー別-2024-2030年の世界予測

3D Cell Culture Market by Product (3D Bio Printing, Magnetic Levitation, Microfluidics-based 3D Cell Culture), Application (Cancer, Drug Discovery, Stem Cell Research), End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=142.54円
3D細胞培養市場：製品、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

3D細胞培養市場規模は2023年に16億2,000万米ドルと推計され、2024年には17億3,000万米ドルに達し、CAGR 7.34%で2030年には26億7,000万米ドルに達すると予測されます。

3D細胞培養の世界市場

主な市場の統計
基準年[2023］ 16億2,000万米ドル
予測年[2024］ 17億3,000万米ドル
予測年 [2030] 26億7,000万米ドル
CAGR（%） 7.34%
3D細胞培養 Market-IMG1

3D細胞培養とは、生物学的細胞を3次元的に拡張できる環境で培養することを指します。この方法は、シャーレのような平らな表面で細胞を培養する従来の2次元の方法とは異なります。3D細胞培養では、細胞は2Dプロトコールに比べ、人体内の細胞の挙動をより忠実に模倣するため、生体内の状態をより正確に解釈することができます。3D細胞培養は、組織再生、がん生物学、創薬など、生物医学研究における重要な分野の研究に役立っています。近年、臓器移植の需要が劇的に増加しており、移植用の生体模倣組織モデルを作成できる3D培養の必要性が高まっています。しかし、3D細胞培養の開発には複雑なインフラが必要であり、またその拡張性にも限界があるため、その採用が妨げられています。マイクロファブリケーションとバイオプリンティング技術の進歩により、3D細胞培養の応用は、実験室内でモデル化されるより複雑な臓器系へと拡大する可能性があります。今後数年間で、3D細胞培養に関する調査活動が活発化し、治療分野への応用が増加すると予想されます。

地域別の洞察

南北アメリカでは、技術の進歩や多額の研究開発投資により、製薬・バイオテクノロジー業界で3D細胞培養の利用が広まっています。多くの現地企業が3D細胞培養システムの製造に取り組んでいます。この地域の包括的な規制の枠組みや細胞研究の重視が、市場をさらに後押ししています。アジア太平洋は、ヘルスケア支出の増加、高齢化人口の増加、多様な慢性疾患の蔓延により、3D細胞培養の新興市場となっています。中国、日本、韓国はバイオテクノロジー分野の著しい成長を目の当たりにしており、これらの培養物の応用と生産をさらに促進しています。ドイツ、英国、フランスは細胞研究に多額の投資を行っており、欧州も重要なプレーヤーです。3D細胞培養は、がん研究、医薬品開発、再生医療に広く使用されています。この地域の企業は、欧州医薬品庁（EMA）などの機関による包括的な規制によって支えられています。他の地域と比較すると、中東・アフリカ地域はあまり発展していませんが、着実に繁栄しています。一般的なヘルスケア意識の高まり、医療インフラへの政府支出、世界製薬企業の急成長がこの地域の成長を物語っています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは3D細胞培養市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、3D細胞培養市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-3D細胞培養市場の市場規模および予測は？

2-3D細胞培養市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-3D細胞培養市場における技術動向と規制の枠組みは？

4-3D細胞培養市場における主要ベンダーの市場シェアは？

5-3D細胞培養市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界的な再生医療への注目の高まり
      • 薬剤耐性と薬剤の再配置のための3D細胞培養の採用
      • 細胞ベースの研究への研究開発活動と投資の増加
    • 抑制要因
      • 3D細胞培養開発には高コストで複雑なインフラストラクチャ要件が必要
    • 機会
      • 精密医療をサポートする3D細胞培養テクノロジーの進歩
      • オルガンオンチップモデルの認識と採用の高まり
    • 課題
      • スケーラビリティが限られており、3D細胞培養が標準化されていない
  • 市場セグメンテーション分析
    • 製品：定性的な利点と機能により、スキャフォールドフリー3D細胞培養が新たに採用されるようになった
    • 応用：薬効を維持するための創薬における3D細胞培養の応用が増加
    • エンドユーザー：細胞の挙動を理解するために調査室で3D細胞培養テクノロジーを採用
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 3D細胞培養市場：製品別

  • 3Dバイオプリンティング
  • 磁気浮上
  • マイクロ流体工学ベースの3D細胞培養
  • スキャフォールドベースの3D細胞培養
  • スキャフォールドフリーの3D細胞培養

第7章 3D細胞培養市場：用途別

  • がん
  • 創薬
  • 幹細胞調査
  • 組織工学と再生医療
  • 毒物学

第8章 3D細胞培養市場：エンドユーザー別

  • 製薬およびバイオテクノロジー企業
  • 調査および研究所

第9章 南北アメリカの3D細胞培養市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の3D細胞培養市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの3D細胞培養市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 3D Biotek, LLC
    • Altis Biosystems, Inc.
    • Avantor, Inc.
    • Becton, Dickinson and Company
    • BellBrook Labs
    • Cellink by Bico Group
    • CN Bio Innovations Limited
    • Copner Biotech
    • Corning Inc.
    • Curesponse Ltd.
    • Electrospinning Company Ltd.
    • Emulate, Inc.
    • Greiner Bio-One International GmbH
    • Hamilton Company
    • InSphero AG
    • JSR Corporation
    • Known Medicine
    • Lonza Group AG
    • Merck KGaA
    • MIMETAS
    • Ovizio Imaging Systems SA/NV
    • PromoCell GmbH
    • Reprocell Inc.
    • SARSTEDT AG & Co. KG
    • Spiderwort Inc.
    • Synthecon Inc.
    • Tecan Trading AG
    • Thermo Fisher Scientific, Inc
    • TissUse GmbH
    • TreeFrog Therapeutics SAS
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. 3D CELL CULTURE MARKET RESEARCH PROCESS
  • FIGURE 2. 3D CELL CULTURE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. 3D CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. 3D CELL CULTURE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. 3D CELL CULTURE MARKET DYNAMICS
  • FIGURE 7. 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. 3D CELL CULTURE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. 3D CELL CULTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. 3D CELL CULTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. 3D CELL CULTURE MARKET SIZE, BY 3D BIO PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. 3D CELL CULTURE MARKET SIZE, BY MAGNETIC LEVITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. 3D CELL CULTURE MARKET SIZE, BY MICROFLUIDICS-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-BASED 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. 3D CELL CULTURE MARKET SIZE, BY SCAFFOLD-FREE 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. 3D CELL CULTURE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. 3D CELL CULTURE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. 3D CELL CULTURE MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. 3D CELL CULTURE MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. 3D CELL CULTURE MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. 3D CELL CULTURE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. 3D CELL CULTURE MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES 3D CELL CULTURE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM 3D CELL CULTURE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. 3D CELL CULTURE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 148. 3D CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. 3D CELL CULTURE MARKET LICENSE & PRICING
目次
Product Code: MRR-43649B5EE3F2

[188 Pages Report] The 3D Cell Culture Market size was estimated at USD 1.62 billion in 2023 and expected to reach USD 1.73 billion in 2024, at a CAGR 7.34% to reach USD 2.67 billion by 2030.

Global 3D Cell Culture Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.62 billion
Estimated Year [2024] USD 1.73 billion
Forecast Year [2030] USD 2.67 billion
CAGR (%) 7.34%
3D Cell Culture Market - IMG1

3D cell culture refers to the practice of growing biological cells in an environment where they can extend in all three dimensions. This method differs from traditional 2D methods that grow cells on flat surfaces, such as petri dishes. In a 3D cell culture, the cells mimic the behavior of cells within the human body much closer compared to 2D protocols, allowing for a more accurate interpretation of in vivo conditions. 3D cell cultures are instrumental in studying critical areas in biomedical research such as tissue regeneration, cancer biology, and drug discovery. The demand for organ transplantations has increased dramatically in recent years, pushing the need for 3D cultures that can create biomimetic tissue models for transplantations. However, complex infrastructure requirements for 3D cell culture development and their limited scalability impede their adoption. With the advancement in microfabrication and bio-printing technologies, the application of 3D cell culture can extend into more complex organ systems to be modeled in the laboratory. In the coming years, we are expected to observe a rise in research activities on 3D cell culture and their increasing applications in therapeutic areas.

Regional Insights

In the American continent, the use of 3D cell culture in the pharma-biotech industry is prevalent due to technological advancement and hefty R&D investments. Many local corporations are working on the production of 3D cell culture systems. The region's comprehensive regulatory frameworks and a strong emphasis on cell research propel the market further. Asia-Pacific is an emerging market for 3D cell culture due to increasing healthcare expenditure, a rise in the aging population, and the prevalence of diverse chronic diseases. China, Japan, and South Korea are witnessing significant growth in the biotechnology sector, which further fuels the application and production of these cultures. Europe is also a significant player, with Germany, UK, and France heavily investing in cell research. 3D cell cultures are extensively used for oncological research, drug development, and regenerative medicines. Companies in the region are supported by comprehensive regulations from agencies, including the European Medicines Agency (EMA). In comparison to other regions, the MEA has a less developed but steadily prospering 3D cell culture scene. Increasing general healthcare awareness, government expenditure on healthcare infrastructure, and the burgeoning presence of global pharmaceutical companies mark the growth in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Cell Culture Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Cell Culture Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Cell Culture Market, highlighting leading vendors and their innovative profiles. These include 3D Biotek, LLC, Altis Biosystems, Inc., Avantor, Inc., Becton, Dickinson and Company, BellBrook Labs, Cellink by Bico Group, CN Bio Innovations Limited, Copner Biotech, Corning Inc., Curesponse Ltd., Electrospinning Company Ltd., Emulate, Inc., Greiner Bio-One International GmbH, Hamilton Company, InSphero AG, JSR Corporation, Known Medicine, Lonza Group AG, Merck KGaA, MIMETAS, Ovizio Imaging Systems SA/NV, PromoCell GmbH, Reprocell Inc., SARSTEDT AG & Co. KG, Spiderwort Inc., Synthecon Inc., Tecan Trading AG, Thermo Fisher Scientific, Inc, TissUse GmbH, and TreeFrog Therapeutics SAS.

Market Segmentation & Coverage

This research report categorizes the 3D Cell Culture Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • 3D Bio Printing
    • Magnetic Levitation
    • Microfluidics-based 3D Cell Culture
    • Scaffold-based 3D Cell Culture
    • Scaffold-free 3D Cell Culture
  • Application
    • Cancer
    • Drug Discovery
    • Stem Cell Research
    • Tissue Engineering & Regenerative Medicine
    • Toxicology
  • End-User
    • Pharmaceutical & Biotechnology Companies
    • Research Laboratories & Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Cell Culture Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Cell Culture Market?

3. What are the technology trends and regulatory frameworks in the 3D Cell Culture Market?

4. What is the market share of the leading vendors in the 3D Cell Culture Market?

5. Which modes and strategic moves are suitable for entering the 3D Cell Culture Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. 3D Cell Culture Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing emphasis on regenerative medicine worldwide
      • 5.1.1.2. Adoption of 3D cell culture for drug resistance and drug repositioning
      • 5.1.1.3. Increasing R&D activities and investments in cell-based studies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complex infrastructure requirements for 3D cell culture development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in 3D cell culture technologies to support precision medicine
      • 5.1.3.2. Emerging awareness and adoption of organ-on-a-chip models
    • 5.1.4. Challenges
      • 5.1.4.1. Limited scalability and lack of standardization of 3D cell culture
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging adoption of scaffold-free 3D cell culture owing to their qualitative benefits and functionalities
    • 5.2.2. Application: Rising application of 3D cell cultures in drug discovery to maintain drug efficacy
    • 5.2.3. End-User: Adoption of 3D cell culture technology in research labs for understanding cell behavior
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. 3D Cell Culture Market, by Product

  • 6.1. Introduction
  • 6.2. 3D Bio Printing
  • 6.3. Magnetic Levitation
  • 6.4. Microfluidics-based 3D Cell Culture
  • 6.5. Scaffold-based 3D Cell Culture
  • 6.6. Scaffold-free 3D Cell Culture

7. 3D Cell Culture Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Drug Discovery
  • 7.4. Stem Cell Research
  • 7.5. Tissue Engineering & Regenerative Medicine
  • 7.6. Toxicology

8. 3D Cell Culture Market, by End-User

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Laboratories & Institutes

9. Americas 3D Cell Culture Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Cell Culture Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Cell Culture Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Agreement, Collaboration, & Partnership
      • 12.3.1.1. InSphero and Advanced BioMatrix Signed a Distribution Agreement to Expand the Application Range in 3d Cell Culture Into Scaffold-Based Models
    • 12.3.2. New Product Launch & Enhancement
      • 12.3.2.1. Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
      • 12.3.2.2. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 3D Biotek, LLC
    • 13.1.2. Altis Biosystems, Inc.
    • 13.1.3. Avantor, Inc.
    • 13.1.4. Becton, Dickinson and Company
    • 13.1.5. BellBrook Labs
    • 13.1.6. Cellink by Bico Group
    • 13.1.7. CN Bio Innovations Limited
    • 13.1.8. Copner Biotech
    • 13.1.9. Corning Inc.
    • 13.1.10. Curesponse Ltd.
    • 13.1.11. Electrospinning Company Ltd.
    • 13.1.12. Emulate, Inc.
    • 13.1.13. Greiner Bio-One International GmbH
    • 13.1.14. Hamilton Company
    • 13.1.15. InSphero AG
    • 13.1.16. JSR Corporation
    • 13.1.17. Known Medicine
    • 13.1.18. Lonza Group AG
    • 13.1.19. Merck KGaA
    • 13.1.20. MIMETAS
    • 13.1.21. Ovizio Imaging Systems SA/NV
    • 13.1.22. PromoCell GmbH
    • 13.1.23. Reprocell Inc.
    • 13.1.24. SARSTEDT AG & Co. KG
    • 13.1.25. Spiderwort Inc.
    • 13.1.26. Synthecon Inc.
    • 13.1.27. Tecan Trading AG
    • 13.1.28. Thermo Fisher Scientific, Inc
    • 13.1.29. TissUse GmbH
    • 13.1.30. TreeFrog Therapeutics SAS
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing